IBDEI0G8 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7878,0)
 ;;=67110^^57^600^12^^^^1
 ;;^UTILITY(U,$J,358.3,7878,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7878,1,2,0)
 ;;=2^Pneumatic Retinopexy
 ;;^UTILITY(U,$J,358.3,7878,1,3,0)
 ;;=3^67110
 ;;^UTILITY(U,$J,358.3,7879,0)
 ;;=92250^^57^600^6^^^^1
 ;;^UTILITY(U,$J,358.3,7879,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7879,1,2,0)
 ;;=2^Fundus Photography
 ;;^UTILITY(U,$J,358.3,7879,1,3,0)
 ;;=3^92250
 ;;^UTILITY(U,$J,358.3,7880,0)
 ;;=66030^^57^601^5^^^^1
 ;;^UTILITY(U,$J,358.3,7880,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7880,1,2,0)
 ;;=2^Inj Treatment of Eye,Medication
 ;;^UTILITY(U,$J,358.3,7880,1,3,0)
 ;;=3^66030
 ;;^UTILITY(U,$J,358.3,7881,0)
 ;;=67028^^57^601^6^^^^1
 ;;^UTILITY(U,$J,358.3,7881,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7881,1,2,0)
 ;;=2^Intravitreal Inj of Eye Drug
 ;;^UTILITY(U,$J,358.3,7881,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,7882,0)
 ;;=67500^^57^601^10^^^^1
 ;;^UTILITY(U,$J,358.3,7882,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7882,1,2,0)
 ;;=2^Retrobulbar Inj,Medication
 ;;^UTILITY(U,$J,358.3,7882,1,3,0)
 ;;=3^67500
 ;;^UTILITY(U,$J,358.3,7883,0)
 ;;=67505^^57^601^9^^^^1
 ;;^UTILITY(U,$J,358.3,7883,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7883,1,2,0)
 ;;=2^Retrobulbar Inj,Alcohol
 ;;^UTILITY(U,$J,358.3,7883,1,3,0)
 ;;=3^67505
 ;;^UTILITY(U,$J,358.3,7884,0)
 ;;=68200^^57^601^13^^^^1
 ;;^UTILITY(U,$J,358.3,7884,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7884,1,2,0)
 ;;=2^Subconjunctival Injection
 ;;^UTILITY(U,$J,358.3,7884,1,3,0)
 ;;=3^68200
 ;;^UTILITY(U,$J,358.3,7885,0)
 ;;=96372^^57^601^11^^^^1
 ;;^UTILITY(U,$J,358.3,7885,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7885,1,2,0)
 ;;=2^SC/IM Injection
 ;;^UTILITY(U,$J,358.3,7885,1,3,0)
 ;;=3^96372
 ;;^UTILITY(U,$J,358.3,7886,0)
 ;;=96402^^57^601^12^^^^1
 ;;^UTILITY(U,$J,358.3,7886,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7886,1,2,0)
 ;;=2^SQ/IM Anti-Neplastic Hormone Inj
 ;;^UTILITY(U,$J,358.3,7886,1,3,0)
 ;;=3^96402
 ;;^UTILITY(U,$J,358.3,7887,0)
 ;;=C9257^^57^601^2^^^^1
 ;;^UTILITY(U,$J,358.3,7887,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7887,1,2,0)
 ;;=2^Bevacizumab Inj 0.25mg
 ;;^UTILITY(U,$J,358.3,7887,1,3,0)
 ;;=3^C9257
 ;;^UTILITY(U,$J,358.3,7888,0)
 ;;=J1094^^57^601^4^^^^1
 ;;^UTILITY(U,$J,358.3,7888,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7888,1,2,0)
 ;;=2^Dexamethasone Acetate Inj per 1mg
 ;;^UTILITY(U,$J,358.3,7888,1,3,0)
 ;;=3^J1094
 ;;^UTILITY(U,$J,358.3,7889,0)
 ;;=J2778^^57^601^8^^^^1
 ;;^UTILITY(U,$J,358.3,7889,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7889,1,2,0)
 ;;=2^Ranibizumab Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,7889,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,7890,0)
 ;;=J3300^^57^601^14^^^^1
 ;;^UTILITY(U,$J,358.3,7890,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7890,1,2,0)
 ;;=2^Triescence Inj per 1mg
 ;;^UTILITY(U,$J,358.3,7890,1,3,0)
 ;;=3^J3300
 ;;^UTILITY(U,$J,358.3,7891,0)
 ;;=J3301^^57^601^7^^^^1
 ;;^UTILITY(U,$J,358.3,7891,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7891,1,2,0)
 ;;=2^Kenalog Inj per 10mg
 ;;^UTILITY(U,$J,358.3,7891,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,7892,0)
 ;;=J3396^^57^601^15^^^^1
 ;;^UTILITY(U,$J,358.3,7892,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7892,1,2,0)
 ;;=2^Verteporfin Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,7892,1,3,0)
 ;;=3^J3396
 ;;^UTILITY(U,$J,358.3,7893,0)
 ;;=J9035^^57^601^3^^^^1
 ;;^UTILITY(U,$J,358.3,7893,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7893,1,2,0)
 ;;=2^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,7893,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,7894,0)
 ;;=J0178^^57^601^1^^^^1
